Literature DB >> 27243553

Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.

Chun Chieh Lin1, Stacey A Fedewa1, Kara K Prickett2, Kristin A Higgins3, Amy Y Chen2.   

Abstract

BACKGROUND: The treatment of patients with advanced stage laryngeal cancer includes surgery or concurrent chemoradiation (CRT). Although CRT has become more common in recent years, to the authors' knowledge, the effectiveness of complete CRT in improving survival over surgery has not been studied.
METHODS: The authors examined patients in the Surveillance, Epidemiology, and End Results (SEER)-Medicare claims-linked data set with locoregional laryngeal cancer who were diagnosed between 1997 and 2007. Multivariate Cox proportional hazard analyses were conducted to compare overall and cause-specific 5-year survival rates between treatment modalities, adjusting for patient sociodemographic and clinical characteristics. A propensity score-matched subcohort also was used to compare survival.
RESULTS: Of the 3212 patients in the study cohort, 42% underwent surgery and 18% underwent CRT. Only approximately one-quarter of patients who were treated with CRT completed the courses. In adjusted analyses, the authors were unable to reject the null hypothesis of no difference in 5-year all-cause or cause-specific mortality risk between patients treated with surgery and patients undergoing complete CRT (hazards ratio, 1.25 [95% confidence interval, 0.91-1.71; P = .16] and hazard ratio, 1.41 [95% confidence interval, 0.9-2.2; P = .14], respectively). Older age, not currently married, Medicaid eligibility, and prior cancer history were found to be associated with a higher risk of mortality (P<.05).
CONCLUSIONS: Patients with advanced laryngeal cancer who underwent complete CRT were found to have overall and cause-specific survival rates similar to those of patients undergoing surgery. However, a substantial percentage of patients who initiated CRT did not complete the course. Although CRT provides organ preservation, the benefits and trade-offs of CRT and total laryngectomy should be discussed fully with patients. The importance of completing the full course of CRT should be emphasized. Cancer 2016.
© 2016 American Cancer Society. Cancer 2016;122:2845-2856. © 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  chemoradiation; comparative effectiveness; laryngeal cancer; surgery; treatment

Mesh:

Year:  2016        PMID: 27243553     DOI: 10.1002/cncr.30122

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Assessing the applications of transitional care and its impact on the quality of life in patients after total laryngectomy.

Authors:  Yingchao Zhu; Dong Chen; Lili Jiang; Leilei Yu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.

Authors:  Wenfei Li; Min Fu; Kun Zhao; Fang Han; Ning Bu; Zhanqiu Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-27       Impact factor: 2.503

3.  Comparison of treatment modalities for selected advanced laryngeal squamous cell carcinoma.

Authors:  Aihemaiti Wushouer; Wenming Li; Minfa Zhang; Dapeng Lei; Xinliang Pan
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-17       Impact factor: 2.503

4.  Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long-term clinical results from a pilot study.

Authors:  Takeharu Ono; Norimitsu Tanaka; Syuichi Tanoue; Yusaku Miyata; Koichiro Muraki; Chiyoko Tsuji; Etsuyo Ogo; Takeichiro Aso; Shun-Ichi Chitose; Buichiro Shin; Tatsuyuki Kakuma; Hidehiro Etoh; Chikayuki Hattori; Toshi Abe; Hirohito Umeno
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-08

5.  Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.

Authors:  Roshanak Derakhshandeh; Sonia Sanadhya; Kyu Lee Han; Haiyan Chen; Olga Goloubeva; Tonya J Webb; Rania H Younis
Journal:  Oncotarget       Date:  2018-01-19

6.  Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147.

Authors:  Li Li; Xiaoxia Dong; Feng Peng; Li Shen
Journal:  Cancer Cell Int       Date:  2018-06-07       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.